Medullary thyroid cancer is a rare tumour that appears in two distinct forms. The rarer familial form is genetically determined. The sporadic form is more common, but its aetiology has not been defined clearly so far. The aim of this study was to examine the risk factors for development of sporadic medullary thyroid cancer (sMTC). A case-control study was carried out during the period 2000-2009. The case group included 98 consecutive patients with sMTC. The control group comprised twice as many cases (196), who were neighbours of the patients from the case group. Patients were individually matched by sex, age and place of residence. Conditional univariate and multivariate logistic regression methods were applied in data analyses. According to the univariate logistic regression method, sMTC was significantly related to smoking status, duration of smoking, number of cigarettes smoked per day, personal history of goitre or thyroid nodules, personal history of nonthyroid cancer, menarche after 14 years of age, first full-term pregnancy before 20 years of age and usage of oral contraceptives. According to the multivariate logistic regression method, sMTC was independently related to smoking status [odds ratio (OR)=0.46, 95% confidence interval (CI)=0.20-0.90], personal history of goitre or thyroid nodules (OR=11.29, 95% CI=1.16-73.45) and menarche after 14 years of age (OR=2.77, 95% CI=1.33-6.28). Risk factors for sMTC were goitre or thyroid nodules and late menarche; cigarette smoking appeared to be a protective factor.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/CEJ.0b013e3283592c78 | DOI Listing |
Clin Pediatr (Phila)
January 2025
Pediatric Dermatology Division, Department of Pediatrics, Imam Hossein Children's Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Extravasation injuries are prevalent in pediatric hospitals and often result in tissue damage and extended hospital stays. However, limited data exist regarding risk factors for extravasation in children. This study aimed to identify these risk factors in pediatric patients receiving intravenous (IV) therapy.
View Article and Find Full Text PDFOral Dis
January 2025
Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba, São Paulo, Brazil.
Objective: To evaluate the frequency of tooth anomalies (TA) in the deciduous and permanent dentition of patients with nonsyndromic orofacial clefts (NSOC), both inside and outside the cleft area.
Methods: The following databases were searched for the relevant literature: Cochrane, OVID, SciELO, Embase, Livivo, PubMed, Scopus, and Web of Science. The risk of bias was analyzed using the Joanna Briggs Institute.
Curr Opin Organ Transplant
January 2025
Department of Community Health.
Purpose Of Review: Disparities in access to transplantation are persistent and pervasive among minoritized populations, and remain incompletely explained by socioeconomic status, insurance, geography, or medical factors. Although much attention has been paid to factors contributing to disparities in organ allocation, fewer studies have focused on barriers to the transplant waitlist. Given increasing calls for equity in organ transplantation, we examine the role of nonmedical factors used in transplant listing decisions, including psychosocial factors like social support, motivation, and knowledge in improving utility in transplant listing decisions, as well as their potential for reinforcing bias.
View Article and Find Full Text PDFCurr Opin Organ Transplant
January 2025
Division of Nephrology, Department of Medicine, Vagelos College of Physicians & Surgeons.
Purpose Of Review: Demonstrate the impact of allocation system design on access to the waitlist and transplantation for patients with end-stage kidney disease (ESKD).
Recent Findings: Minoritized groups are more likely to be declined from transplant listing owing to psychosocial criteria. Lack of consistent definitions, screening tools with differential subgroup validity, and insufficient evidence-base contribute to concerns about reliance on psychosocial factors in transplant listing decisions.
Crohns Colitis 360
January 2025
Department of Gastroenterology and Liver Services, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
Background And Aims: Vedolizumab is s gut-selective advanced therapy that is safe and efficacious for the treatment of ulcerative colitis (UC). Once patients achieve successful induction, there is a risk of loss of response leading to eventual flare. We aimed to identify these predictive factors and develop a practical scoring system to determine the ongoing efficacy of vedolizumab.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!